Supplementary Figure Legends
Supplemental Table 1 Table 7 : Genes up-regulated ≥2-fold identified as overlapping between 0.5 mM metformin, 1.0 mM metformin and 500 nm rapamycin treated fibroblast datasets from RNAseq. Table 8 : Genes down-regulated ≥2-fold identified as overlapping between 0.5 mM metformin, 1.0 mM metformin and 500 nm rapamycin treated fibroblast datasets from RNAseq. Supplemental Table 9 : Biological pathway enrichment of networks constructed from shared and not shared genes ≥2-fold upregulated or downregulated in response to 0.5 and 1.0 mM metformin.
Supplemental
The enriched pathway annotation terms (GeneSet) are listed. P-value and false discovery rates are presented. Nodes lists genes from our data set present in the enriched pathway. Absence of pathways indicates no enrichment in a given dataset. Table 10 : Biological pathway enrichment of ≥2-fold upregulated genes common to 0.5 mM metformin, 1.0 mM metformin and 500 nm rapamycin treated fibroblasts. No pathway enrichment was present in common ≥2-fold downregulated genes.

